Tue, September 17, 2024
AUS Edition NZ Edition UK Edition CA Edition USA Edition FRA Edition GER Edition ESP Edition ITA Edition NLD Edition
PRT Edition SWE Edition GRC Edition IND Edition POL Edition BRA Edition ZAF Edition RUS Edition CHN Edition UAE Edition
Kalkine Media ASX Share Market News & Research
Kalkine Media ASX Share Market News & Research
  1. Home
  2. Companies
  3. AVR
Healthcare
Facebook Twitter Linkedin

Anteris Technologies Ltd (ASX:AVR)

12.7 AUD

-0.440 3.349%
Last Updated at: 2024-09-16T06:10:00Z

Anteris Technologies Ltd

Anteris Technologies Ltd, a structural heart company, engages in the designing, developing, and commercializing medical devices. The company's lead product candidate is DurAVR, a transcatheter heart valve (THV) for the treatment of aortic stenosis. It also offers ComASUR, a delivery system that provides controlled deployment and placement of the DurAVR THV with balloon-expandable delivery, which allow precise alignment of the heart's native commissures to achieve ideal valve positioning; and ADAPT, a patented anti-calcification tissue technology. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.

Toowong Tower, Toowong, QLD, Australia, 4066

61 13 0055 0310

https://anteristech.com

Key Executives

Sr. No. Name Title Year Born
1. Mr. Wayne G. Paterson CEO, MD & Exec. Director 1967
2. Mr. Matthew McDonnell Chief Financial Officer NA
3. Mr. David St. Denis Chief Operating Officer NA
4. Mr. Stephen Denaro Independent Non-Exec. Director & Company Sec. NA
5. Mr. Chris Olig Bus. Devel. and Portfolio Planning Director NA
6. Dr. Chris Meduri M.D., M.P.H. Chief Medical Officer & Member of Medical Advisory Board NA
7. Mr. Danny Zanardo Commercial Director of International NA
8. Prof. Ian Hector Frazer AC, FAA, FRS, M.D. Exec. NA
9. Mr. Wayne G. Paterson CEO, MD & Executive Director 1967
10. Mr. Stephen Denaro Independent Non-Executive Director & Company Secretary NA

Peers

Sector: Healthcare

Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE(x) Forward PE(x) Price Sales TTM(x) Price to Book Value(x) Enterprise Value to Revenue(x) Enterprise Value to EBITDA(x)
COH

Cochlear Ltd

 -0.730 0.251% 292.11 53.580 44.843 8.524 10.179 8.259 31.895
PNV

Polynovo Ltd

 -0.130 5.039% 2.59 253.500 169.492 16.995 24.324 16.705 425.940
AVH

Avita Therapeutics Inc

 +0.230 8.214% 3 0.000 0.000 6.901 10.056 4.347 -10.054
EBR

Ebr Systems Inc CDR

 -0.035 3.684% 0.95 0.000 0.000 0.000 18.302 0.000 -3.679

Income Statement

(Currency in AUD)
Breakdown 31-12-2022 31-12-2021 31-12-2020 31-12-2019 31-12-2018
Income Before Tax -44.34M -22.907M -15.275M -6.181M -24.699M
Minority Interest - - - 0.362M 0.362M
Net Income -45.253M -25.772M -17.52M -30.752M -24.217M
Selling General Administrative 22.449M 13.951M 11.765M 20.944M 23.523M
Gross Profit 2.609M 6.151M 6.514M 8.303M 12.438M
Reconciled Depreciation 1.742M 1.354M 1.213M 1.616M 1.411M
Ebit -43.427M -21.566M -14.902M -1.109M -21.579M
Ebitda -41.685M -20.211M -13.69M 0.508M -20.168M
Depreciation And Amortization 1.742M 1.354M 1.213M 1.616M 1.411M
Operating Income -43.427M -21.566M -14.902M -1.109M -23.264M
Other Operating Expenses 51.976M 30.799M 25.99M 42.649M 48.865M
Interest Expense 0.913M 1.342M 0.372M 0.29M 2.638M
Tax Provision 0M 0M 0M 0M 0M
Interest Income 0.308M 0.091M 0.185M 0.066M 0.042M
Net Interest Income -0.769M -1.423M -0.187M -0.224M -2.596M
Income Tax Expense 0.913M 2.865M 2.245M 24.57M -
Total Revenue 4.59M 7.791M 9.236M 17.075M 25.601M
Total Operating Expenses 49.994M 29.159M 23.267M 33.876M 35.702M
Cost Of Revenue 1.981M 1.64M 2.723M 8.773M 13.163M
Total Other Income Expense Net -0.913M -1.342M -0.372M -5.073M -1.435M
Net Income From Continuing Ops -44.34M -22.907M -15.275M -6.181M -24.699M
Net Income Applicable To Common Shares -44.34M -22.907M -15.275M -5.82M -24.217M

Balance Sheet

(Currency in AUD)
Breakdown 31-12-2023 31-12-2022 31-12-2021 31-12-2020 31-12-2019
Total Assets 45.701M 23.479M 29.482M 12.651M 26.004M
Intangible Assets - 0.896M 1.145M 1.416M 1.699M
Other Current Assets 3.138M 1.404M 1.196M 1.46M 1.73M
Total Liab 17.039M 10.262M 15.134M 10.244M 10.469M
Total Stockholder Equity 28.602M 13.218M 14.348M 2.407M 15.535M
Other Current Liab 8.258M 4.234M 4.562M 0.4M 0.4M
Common Stock 282.988M 211.832M 172.638M 138.74M 137.758M
Capital Stock - 211.832M 172.638M 138.74M 137.758M
Retained Earnings -270.424M -202.02M -157.68M -134.773M -119.498M
Good Will - - - 0M 0M
Other Assets 0M - - 0.711M 0.73M
Cash 30.832M 13.805M 21.3M 4.354M 8.968M
Cash And Equivalents - - - - -
Total Current Liabilities 13.825M 7.541M 12.942M 7.839M 7.302M
Current Deferred Revenue - - - 3.731M 4.324M
Net Debt -28.499M -12.399M -15.57M -0.571M -6.351M
Short Term Debt 0.978M 0.757M 5.308M 2.954M 1.453M
Short Long Term Debt - - 4.683M 2.554M 1.113M
Short Long Term Debt Total 2.333M 1.406M 5.729M 3.783M 2.617M
Other Stockholder Equity - -1.507M -0.611M -1.56M -2.724M
Property Plant Equipment - 4.517M 2.497M 2.431M 2.964M
Total Current Assets 35.886M 18.066M 25.839M 8.093M 20.583M
Long Term Investments - - - - -
Short Term Investments - 0.089M 0.089M 0.111M 7.137M
Net Receivables 1.27M 0.832M 2.585M 1.585M 2.665M
Long Term Debt - 1.382M 1.21M 0.938M 1.003M
Inventory 0.647M 0.525M 0.758M 0.693M 1.812M
Accounts Payable 4.589M 2.549M 3.072M 0.755M 1.126M
Accumulated Other Comprehensive Income 16.038M 3.405M -0.611M -1.56M -2.724M
Non Currrent Assets Other 1.378M - - 0.711M 0.73M
Non Current Assets Total 9.815M 5.414M 3.642M 4.559M 5.421M
Capital Lease Obligations - 1.406M 1.047M 1.229M 1.505M
Long Term Debt Total - 2.031M 1.632M 1.767M 2.168M

Cash Flow

(Currency in AUD)
Breakdown 31-12-2022 31-12-2021 31-12-2020 31-12-2019 31-12-2018
Investments -1.36M -0.4M 7.109M -7.537M -0.4M
Total Cashflows From Investing Activities -1.36M -1.162M 7.763M 20.573M -1.011M
Total Cash From Financing Activities 31.364M 36.908M 1.893M 0.009M 27.149M
Net Income -45.253M -22.907M -15.275M -5.82M -24.217M
Change In Cash -7.495M 16.946M -4.614M -3.068M 3.781M
Begin Period Cash Flow 21.3M 4.354M 8.968M 12.036M 8.255M
End Period Cash Flow 13.805M 21.3M 4.354M 8.968M 12.036M
Total Cash From Operating Activities -43.511M -18.81M -14.373M -22.867M -22.205M
Depreciation 1.742M 1.354M 1.213M 1.616M 1.411M
Other Cashflows From Investing Activities 1.049M -0.39M 8.052M 20.64M -0.4M
Dividends Paid - 5M - - -
Change To Inventory 0.233M -0.064M 1.119M 2.034M -1.138M
Sale Purchase Of Stock -1.468M -1.09M 1.068M -0.641M -3.069M
Other Cashflows From Financing Activities -0.713M 8.943M 0.825M 0.649M 4.807M
Capital Expenditures 2.409M 0.773M 0.289M 0.067M 0.611M
Change In Working Capital 1.846M 1.602M 2.446M 0.048M 0.076M
Other Non Cash Items 43.511M 21.553M 14.062M 4.203M 22.806M
Free Cash Flow -45.92M -19.582M -14.662M -22.934M -22.817M

No data found

Disclaimer

Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Related Articles

Code Price Chg %Chg
View All
Code Price Chg %Chg
View All
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Open in the App